Flow diagram of the patient selection into the final analysis. by Zi-Rong Chen (9227618)

Subjects:

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

Subjects:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean  by Beatrice T. Nganso (4114768)

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Significant associations in GWAS. by Dai Nogimura (21445649)

Subjects:

Bias risk assessments for each RCT study. by Xin Liu (43569)

Subjects:

The flow chart of studies selecting. by Xin Liu (43569)

Subjects:

Forest plot of the effect of high-dose TXA on transfusion rate. by Xin Liu (43569)

Subjects:

Forest plot of the effect of high-dose TXA on intraoperative blood loss. by Xin Liu (43569)

Subjects:

Forest plot of the effect of high-dose TXA on operation time. by Xin Liu (43569)

Subjects:

Characteristics of the included studies. by Xin Liu (43569)

Subjects:

Funnel plots for intraoperative blood loss. by Xin Liu (43569)

Subjects:

Bias risk assessments for each RCS study. by Xin Liu (43569)

Subjects:

Summary of results. by Xin Liu (43569)

Subjects:

Prisma flow diagram of study selection. by Hattapark Dejakaisaya (22238613)

Subjects: